Aclidinium Bromide bulk supplier for pharma manufacturers

Aclidinium Bromide 400 mcg Suppliers & Bulk Manufacturers

Available Forms: inhalation powder

Available Strengths: 400 mcg

Reference Brands: Tudorza Pressair (USA), Eklira Genuair (EU)

Aclidinium bromide 400 microgram inhalation powder in a multidose dry powder inhaler, a twice-daily LAMA for COPD maintenance, for importers, distributors and hospital respiratory buyers.

Get Enquiry / Request Bulk Quote

Usually answered within 48 hours | GMP documents shared before you commit

Manufacture or export Aclidinium Bromide? List it or send an offer →

Product Description:

Aclidinium bromide is a long-acting muscarinic antagonist (LAMA). It blocks M3 receptors on airway smooth muscle, so acetylcholine can no longer tighten the bronchi, and the airways stay wider for about twelve hours. Once absorbed it is quickly broken down in plasma to inactive products, keeping systemic anticholinergic exposure low. This page lists 400 micrograms per actuation as a dry powder in a breath-actuated multidose inhaler, with a dose indicator and a coloured window that confirms correct inhalation, and no capsules to load.

It is a maintenance bronchodilator for chronic obstructive pulmonary disease, inhaled twice daily. It is not for sudden breathlessness, so patients keep a short-acting reliever. The patient presses and releases the button, breathes out away from the device, then inhales quickly and deeply. Anticholinergic effects call for caution in narrow-angle glaucoma, urinary retention and prostatic enlargement. Paradoxical bronchospasm means stopping at once. The powder contains lactose, and the US label warns against use in severe milk protein allergy.

Sourcing notes. An inhaled product is drug and device together, so any alternative source needs evidence of equivalent delivered dose and fine particle fraction from a comparable inhaler. Labels may state the metered 400 micrograms or the lower delivered amount, so match the declared strength to your registration. Each inhaler is sealed in a protective pouch and has a limited in-use period after opening; no cold chain is needed. Ask for a CoA per batch with delivered dose uniformity and aerodynamic particle size, plus the GMP certificate, a CoPP and a CTD dossier. It is prescription-only.

Aclidinium Bromide — third party manufacturing & bulk supply

Aclidinium Bromide 400 mcg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Aclidinium Bromide is supplied as inhalation powder — a dosage form priced by order value, so the indicative MOQ is a minimum order value of USD 5,000 per product. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Aclidinium Bromide listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Aclidinium Bromide →

Usually answered within 48 hours, with matched manufacturers, indicative prices and document status.

Back to Listing

Frequently Asked Questions

Aclidinium bromide is used as a long-term maintenance treatment to relieve symptoms of chronic obstructive pulmonary disease, including chronic bronchitis and emphysema, by improving airflow and reducing breathlessness.

Aclidinium bromide is a synthetic quaternary ammonium compound that acts as a selective muscarinic receptor antagonist, particularly targeting M3 receptors in the lungs to induce bronchodilation.

Aclidinium bromide is marketed under trade names such as Tudorza Pressair in the United States and Eklira Genuair in the European Union and the United Kingdom.

Aclidinium bromide was originally developed by Almirall and is marketed globally by Almirall and its partners, with additional manufacturers producing approved generic versions in regulated markets.

The generic name of the drug is aclidinium bromide.

The brand names of aclidinium bromide include Tudorza Pressair and Eklira Genuair.

Aclidinium bromide is manufactured by various pharmaceutical companies in different countries under regulatory approvals for markets such as the USA, EU, and UK.